Rigel Pharmaceuticals Inc · Cash & Short-Term Investments

Latest reported$154.96Mperiod endingDec 31, 2025

RIGL FY Cash & Short-Term Investments ($5.84M → $154.96M)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

RIGL cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Rigel Pharmaceuticals Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	154,955,000
Dec 31, 2024	77,321,000
Dec 31, 2023	56,933,000
Dec 31, 2022	58,206,000
Dec 31, 2021	124,967,000
Dec 31, 2020	57,327,000
Dec 31, 2019	98,078,000
Dec 31, 2018	128,537,000
Dec 31, 2017	115,751,000
Dec 31, 2016	74,766,000
Dec 31, 2015	126,276,000
Dec 31, 2014	143,159,000
Dec 31, 2013	211,975,000
Dec 31, 2012	298,241,000
Dec 31, 2011	247,640,000
Dec 31, 2010	177,295,000
Dec 31, 2009	133,318,000
Dec 31, 2008	134,477,000
Dec 31, 2007	108,296,000
Dec 31, 2006	104,471,000
Dec 31, 2005	138,196,000
Dec 31, 2004	71,427,000
Dec 31, 2003	46,500,000
Dec 31, 2002	27,291,000
Dec 31, 2001	33,415,000
Dec 31, 2000	52,994,000
Dec 31, 1999	5,836,000